Trade SPRY stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
ARS Pharmaceuticals, Inc. (SPRY) is trading at US$4.35, up 5.84% today as of Sep 21, 16:00 EDT. The company has a market capitalisation of US$547.46M. Over the past 52 weeks, SPRY has traded between US$4.07 and US$13.15. On Syfe you can trade SPRY with $0 commission and add it to your watchlist.
| Previous close | US$4.11 |
|---|---|
| Market cap | US$547.46M |
| 52-week range | US$4.07 – US$13.15 |
| Volume | 1.19M |
| Exchange | US |
Add to Watchlist
Set Price Alert
ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.
Year: 2022
ARS Pharmaceuticals Names Donn Casale as CEO as Richard Lowenthal Departs
Jul 7, 9:02 PM · MT Newswires
Top Premarket Decliners
Jun 25, 11:40 AM · MT Newswires
ARS Pharmaceuticals Updates Neffy Coverage Outlook, Cuts 2026 Costs
Jun 25, 10:48 AM · MT Newswires
Sector Update: Healthcare Stocks Decline Late Afternoon
May 15, 7:52 PM · MT Newswires
Sector Update: Healthcare Stocks Softer Friday Afternoon
May 15, 5:51 PM · MT Newswires
ARS Pharmaceuticals, Inc. (SPRY) stock is trading at US$4.35, +5.84% from the previous close of US$4.11.
The market cap for ARS Pharmaceuticals, Inc. (SPRY) stock is approximately US$547.46M.
The 52-week high for ARS Pharmaceuticals, Inc. (SPRY) stock is US$13.15.
The 52-week low for ARS Pharmaceuticals, Inc. (SPRY) stock is US$4.07.
ARS Pharmaceuticals, Inc. (SPRY) does not currently pay a dividend.
Stay on top of SPRY
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
